These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
821 related items for PubMed ID: 26924200
1. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. Christensen GJ, Scholz CF, Enghild J, Rohde H, Kilian M, Thürmer A, Brzuszkiewicz E, Lomholt HB, Brüggemann H. BMC Genomics; 2016 Feb 29; 17():152. PubMed ID: 26924200 [Abstract] [Full Text] [Related]
2. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris. Nakase K, Yoshida A, Saita H, Hayashi N, Nishijima S, Nakaminami H, Noguchi N. J Dermatol; 2019 Sep 29; 46(9):782-786. PubMed ID: 31254314 [Abstract] [Full Text] [Related]
3. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Wang Y, Kuo S, Shu M, Yu J, Huang S, Dai A, Two A, Gallo RL, Huang CM. Appl Microbiol Biotechnol; 2014 Jan 29; 98(1):411-24. PubMed ID: 24265031 [Abstract] [Full Text] [Related]
4. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions. Holland KT, Cunliffe WJ, Eady EA. J Med Microbiol; 1979 Feb 29; 12(1):71-82. PubMed ID: 34728 [Abstract] [Full Text] [Related]
6. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. Nishijima S, Kurokawa I, Katoh N, Watanabe K. J Dermatol; 2000 May 29; 27(5):318-23. PubMed ID: 10875198 [Abstract] [Full Text] [Related]
7. Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. Tomida S, Nguyen L, Chiu BH, Liu J, Sodergren E, Weinstock GM, Li H. mBio; 2013 Apr 30; 4(3):e00003-13. PubMed ID: 23631911 [Abstract] [Full Text] [Related]
9. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes. Poomanee W, Chaiyana W, Mueller M, Viernstein H, Khunkitti W, Leelapornpisid P. Anaerobe; 2018 Aug 30; 52():64-74. PubMed ID: 29906773 [Abstract] [Full Text] [Related]
10. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. Nishijima S, Akamatsu H, Akamatsu M, Kurokawa I, Asada Y. J Dermatol; 1994 Mar 30; 21(3):166-71. PubMed ID: 8014270 [Abstract] [Full Text] [Related]
11. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls. Lomholt HB, Scholz CFP, Brüggemann H, Tettelin H, Kilian M. Anaerobe; 2017 Oct 30; 47():57-63. PubMed ID: 28434779 [Abstract] [Full Text] [Related]
12. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S. Br J Dermatol; 2001 Feb 30; 144(2):339-46. PubMed ID: 11251569 [Abstract] [Full Text] [Related]
13. [A comparison of biochemical and genetic classification of propionibacterium acnes strains isolated from skin lesions of patients with acne]. Kasprowicz A, Owczarek MM, Miedzobrodzki J, Białecka A. Med Dosw Mikrobiol; 2012 Feb 30; 64(3):203-10. PubMed ID: 23285774 [Abstract] [Full Text] [Related]
14. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study. Alkhawaja E, Hammadi S, Abdelmalek M, Mahasneh N, Alkhawaja B, Abdelmalek SM. BMC Dermatol; 2020 Nov 17; 20(1):17. PubMed ID: 33203374 [Abstract] [Full Text] [Related]
15. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria. Owen L, Grootveld M, Arroo R, Ruiz-Rodado V, Price P, Laird K. Phytother Res; 2017 Mar 17; 31(3):410-417. PubMed ID: 28124400 [Abstract] [Full Text] [Related]
16. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris. Giannopoulos L, Papaparaskevas J, Refene E, Daikos G, Stavrianeas N, Tsakris A. Anaerobe; 2015 Feb 17; 31():50-4. PubMed ID: 25451716 [Abstract] [Full Text] [Related]
17. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM, Li H. J Invest Dermatol; 2013 Sep 17; 133(9):2152-60. PubMed ID: 23337890 [Abstract] [Full Text] [Related]
18. Antibiotic resistance of microbial strains isolated from Korean acne patients. Moon SH, Roh HS, Kim YH, Kim JE, Ko JY, Ro YS. J Dermatol; 2012 Oct 17; 39(10):833-7. PubMed ID: 22779738 [Abstract] [Full Text] [Related]
19. A Microtube Array Membrane (MTAM) Encapsulated Live Fermenting Staphylococcus epidermidis as a Skin Probiotic Patch against Cutibacterium acnes. Yang AJ, Marito S, Yang JJ, Keshari S, Chew CH, Chen CC, Huang CM. Int J Mol Sci; 2018 Dec 20; 20(1):. PubMed ID: 30577530 [Abstract] [Full Text] [Related]
20. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. Dréno B, Pécastaings S, Corvec S, Veraldi S, Khammari A, Roques C. J Eur Acad Dermatol Venereol; 2018 Jun 20; 32 Suppl 2():5-14. PubMed ID: 29894579 [Abstract] [Full Text] [Related] Page: [Next] [New Search]